Cargando…
Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis
PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic and immune-mediated disease, which is characterized by the progressive destruction of pancreatic beta cells. T1DM precipitates in genetically susceptible individuals through environmental factors. In this study, we aimed to evaluate the impact of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106689/ https://www.ncbi.nlm.nih.gov/pubmed/30032588 http://dx.doi.org/10.3345/kjp.2018.61.7.217 |
_version_ | 1783349826321121280 |
---|---|
author | Gürsoy, Semra Koçkar, Tuba Atik, Sezen Ugan Önal, Zerrin Önal, Hasan Adal, Erdal |
author_facet | Gürsoy, Semra Koçkar, Tuba Atik, Sezen Ugan Önal, Zerrin Önal, Hasan Adal, Erdal |
author_sort | Gürsoy, Semra |
collection | PubMed |
description | PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic and immune-mediated disease, which is characterized by the progressive destruction of pancreatic beta cells. T1DM precipitates in genetically susceptible individuals through environmental factors. In this study, we aimed to evaluate the impact of autoimmunity and intestinal colonization of Candida albicans on the development of T1DM. METHODS: Forty-two patients newly diagnosed with T1DM and 42 healthy subjects were included in this monocentric study. The basic and clinical characteristics of the patients were recorded. T1DM-, thyroid-, and celiac-associated antibodies were evaluated. Stool cultures for C. albicans were performed to assess whether or not gut integrity was impaired in patients with T1DM. RESULTS: The evaluation of T1DM- and thyroid-associated antibodies showed that the prevalences of islet cell antibodies and antithyroperoxidase positivity were higher in the study patients than in the patients in the control group. Furthermore, the direct examination and culture of fresh stool samples revealed that 50% of the patients with T1DM and 23.8% of the control subjects had fungi (C. albicans). CONCLUSION: Through this study, we suggest that the presence of intestinal C. albicans colonization at the time of the diagnosis of T1DM may indicate impairment of normal intestinal microbiota. We also suggest that there may be a tendency of T1DM in patients with a high prevalence of intestinal C. albicans. |
format | Online Article Text |
id | pubmed-6106689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Korean Pediatric Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-61066892018-08-29 Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis Gürsoy, Semra Koçkar, Tuba Atik, Sezen Ugan Önal, Zerrin Önal, Hasan Adal, Erdal Korean J Pediatr Original Article PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic and immune-mediated disease, which is characterized by the progressive destruction of pancreatic beta cells. T1DM precipitates in genetically susceptible individuals through environmental factors. In this study, we aimed to evaluate the impact of autoimmunity and intestinal colonization of Candida albicans on the development of T1DM. METHODS: Forty-two patients newly diagnosed with T1DM and 42 healthy subjects were included in this monocentric study. The basic and clinical characteristics of the patients were recorded. T1DM-, thyroid-, and celiac-associated antibodies were evaluated. Stool cultures for C. albicans were performed to assess whether or not gut integrity was impaired in patients with T1DM. RESULTS: The evaluation of T1DM- and thyroid-associated antibodies showed that the prevalences of islet cell antibodies and antithyroperoxidase positivity were higher in the study patients than in the patients in the control group. Furthermore, the direct examination and culture of fresh stool samples revealed that 50% of the patients with T1DM and 23.8% of the control subjects had fungi (C. albicans). CONCLUSION: Through this study, we suggest that the presence of intestinal C. albicans colonization at the time of the diagnosis of T1DM may indicate impairment of normal intestinal microbiota. We also suggest that there may be a tendency of T1DM in patients with a high prevalence of intestinal C. albicans. Korean Pediatric Society 2018-07 2018-07-15 /pmc/articles/PMC6106689/ /pubmed/30032588 http://dx.doi.org/10.3345/kjp.2018.61.7.217 Text en Copyright © 2018 by The Korean Pediatric Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Gürsoy, Semra Koçkar, Tuba Atik, Sezen Ugan Önal, Zerrin Önal, Hasan Adal, Erdal Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis |
title | Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis |
title_full | Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis |
title_fullStr | Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis |
title_full_unstemmed | Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis |
title_short | Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis |
title_sort | autoimmunity and intestinal colonization by candida albicans in patients with type 1 diabetes at the time of the diagnosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106689/ https://www.ncbi.nlm.nih.gov/pubmed/30032588 http://dx.doi.org/10.3345/kjp.2018.61.7.217 |
work_keys_str_mv | AT gursoysemra autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis AT kockartuba autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis AT atiksezenugan autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis AT onalzerrin autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis AT onalhasan autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis AT adalerdal autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis |